Generation of pure GABAergic neurons by transcription factor programming.
- Authors
- Yang, Nan; Chanda, Soham; Marro, Samuele; Ng, Yi-Han; Janas, Justyna A; Haag, Daniel; Ang, Cheen Euong; Tang, Yunshuo; Flores, Quetzal; Mall, Moritz; Wapinski, Orly; Li, Mavis; Ahlenius, Henrik; Rubenstein, John L; Chang, Howard Y; Buylla, Arturo Alvarez; SΓΌdhof, Thomas C; Wernig, Marius
- Year
- 2017
- Journal
- Nature methods
- PMID
- 28504679
- DOI
- 10.1038/nmeth.4291
- PMCID
- PMC5567689
Approaches to differentiating pluripotent stem cells (PSCs) into neurons currently face two major challenges-(i) generated cells are immature, with limited functional properties; and (ii) cultures exhibit heterogeneous neuronal subtypes and maturation stages. Using lineage-determining transcription factors, we previously developed a single-step method to generate glutamatergic neurons from human PSCs. Here, we show that transient expression of the transcription factors Ascl1 and Dlx2 (AD) induces the generation of exclusively GABAergic neurons from human PSCs with a high degree of synaptic maturation. These AD-induced neuronal (iN) cells represent largely nonoverlapping populations of GABAergic neurons that express various subtype-specific markers. We further used AD-iN cells to establish that human collybistin, the loss of gene function of which causes severe encephalopathy, is required for inhibitory synaptic function. The generation of defined populations of functionally mature human GABAergic neurons represents an important step toward enabling the study of diseases affecting inhibitory synaptic transmission.
Rapid and efficient generation of human inhibitory iN cells with Ascl1, Dlx2 and Myt1l. (a) Identification of transcription factor (TF) combinations to generate GABAergic neurons. TF combinations give rise to different fractions of iN cells (pie charts) with spontaneous EPSCs (magenta), IPSCs (blue) or mixed postsynaptic currents (green) and varying frequencies (mean Β± s.e.m.; n = 5β7 cells) of EPSCs and IPSCs (histograms). Filled circles represent values measured from individual cells. (b) Representative images of AMD-iN cells 5 weeks after infection (4 weeks after coculture with mouse glia). iN cells were detected with antibodies against MAP2 and Human Nuclear Antigen (HuNu). Bar graphs show percentage of HuNu-positive cellsthat express neuronal marker MAP2 (n = 3 independent experiments). (cβg) MAP2-expressing AMD-iN cells colabel with additional GABAergic markers including DLX proteins, GAD1/2 (GAD67/GAD65), GABA and vGAT. (h) Repetitive series of action potentials (APs) in response to step-current injections in AMD-iN cells. (i) Intrinsic and active membrane properties of AMD-iN cells observed as AP generation in response to amplitude of step-current stimulation (left); resting membrane potential (Vrest), AP threshold (APt), AP height (APh) and after hyperpolarization potentials (AHP) (second left); membrane capacitance (Cm, second right) and input resistance (Rm, right). Values are mean Β± s.e.m. (n = 8β18 cells). (j) Spontaneous IPSCs recorded from AMD-iN cells. (k) Evoked IPSCs in AMD-iN cells as elicited by single (top left) or a train (top right) of stimulation (triangles). Inset, expanded view of asynchronous delayed IPSCs. Evoked IPSC amplitude (bar graph) and synaptic depression (filled circles) are presented as mean Β± s.e.m. (l,m) AMD-iN cells received spontaneous excitatory (red asterisk and example trace) and inhibitory (blue asterisk and example trace) synaptic inputs when cocultured with Ngn2-iN cells. Pie chart indicates percentages of synaptic event types (IPSC, blue; EPSC, red) recorded from an AMD-iN cell cocultured with Ngn2-induced neurons. Scale bars, 50 um (b,cβf,l).
LLM interpretation
This figure presents the characterization of human inhibitory neurons (iN cells) generated using various transcription factor combinations, specifically Ascl1, Dlx2, and Myt1l (AMD). Panel (a) uses pie charts and histograms to compare synaptic event types and frequencies across different TF combinations, while panels (bβg) utilize immunofluorescence microscopy and bar graphs to show the expression of neuronal (MAP2) and GABAergic markers (DLX, GAD1/2, GABA, vGAT). Panels (hβm) provide electrophysiological data, including action potential traces, membrane property plots, and recordings of spontaneous and evoked IPSCs/EPSCs. Quantitative data are presented as mean Β± s.e.m., with significance markers (asterisks) indicated in the frequency histograms of panel (a).
Transient expression of Ascl1 and Dlx2 (AD) generates GABAergic iN cells from human ES cells. (a) Omission of Myt1l slows the formation of neuronal morphologies, but exogenous Myt1l is not necessary for neuronal induction mediated by Ascl1 and Dlx2. (b) Endogenous MYT1 family members are induced in AD-transduced human ES cells (qRT-PCR results expressed as log2 fold change between AD-transduced cells and human ES cells. Mean Β± s.e.m., n = 3 biological replicates). (c) MYT1L protein is present in AD-iN cells 5 weeks postinfection. (d) Lentiviral vectors and timeline for GABAergic iN cell induction. Cells are transduced with three viruses expressing rtTA, a fused Ascl1-T2A-puromycin resistance gene, and a fused Dlx2-hygromycin resistance gene. (e) AD-iN cells express telencephalic marker FOXG1 and GABAergic neuron markers (GABA, DLX proteins, GAD1/2 (GAD67/65)). (f) MAP2-positive cells coexpress GABA, DLX proteins or GAD1/2 (GAD65/67) after 5 weeks of conversion. (g) qRT-PCR analysis in AMD and AD-iN cells (5 WPI) cultured on mouse glia (three biological replicates each), mouse glia, and Ngn2-iN cells (i) or EGFP-sorted AD-iN cells (ii and iii) after coinfection of hES cells with a constitutive EGFP virus. (h) AD- iN cells cocultured with mouse glia for 4 weeks show highly branched MAP2-positive neurons that coimmunostain for CB, CR and SST. Expression of CB and SST or CR and SST is largely nonoverlapping. (i) Quantification of marker overlap. (mean Β± s.e.m., n = 3 biological replicates). (j) PV-expressing AD-iN cells were detected. (k) Single-cell qRT-PCR analysis of 64 AD-iN cells for genes indicated on the left. Ct, crossing threshold (g,k). Scale bars, 50um (a,e,h,j).
LLM interpretation
This multi-panel figure demonstrates the generation of GABAergic induced neurons (iNs) from human ES cells using Ascl1 and Dlx2 (AD). It includes microscopy images showing neuronal morphology (MAP2) and expression of GABAergic markers (FOXG1, GABA, DLX, GAD1/2, CB, CR, SST, PV), a line graph of MYT1 family induction, and a Western blot confirming MYT1L protein presence. Quantitative data are presented via a bar chart of marker expression in MAP2+ cells and heatmaps showing gene expression profiles via qRT-PCR and single-cell analysis.
Functional maturation and synaptic integration of AD-iN cells in vitro and long-term stability of GABAergic fate in vivo. (a) Current injection-induced action potentials recorded from AD-iN cells as replated on mouse glia for 4 to 6 weeks (red and blue, respectively) or when cocultured with Ngn2-induced excitatory neurons for 6 weeks (brown). (b) AP-generation properties (i) measured as number of APs generated with current-pulse amplitude (left) and as resting membrane potential (Vrest), AP threshold (APt), AP height (APh) and after-hyperpolarization potentials (AHP) (right); and intrinsic properties (ii) measured as membrane capacitance (Cm, left) and input resistance (Rm, right). All values are mean Β± s.e.m. (n = 14 cells, 5 WPI; n = 12 cells, 7 WPI;n = 32 cells, 7 WPI Ngn2-iN coculture; Studentβs t-test; *, P > 0.05). (c) Sample traces (left) of spontaneous IPSCs and event amplitude and frequency (mean Β± s.e.m., right), as recorded from AD-iN cells cocultured with mouse glia for 4 weeks (red) or 6 weeks (blue). (d) Sample traces of train-stimulation-induced evoked IPSCs (left) and first IPSC amplitude and total charge transfer from IPSC trains (mean Β± s.e.m., right) recorded from AD-iN cells when coculturedwith mouse glia for 4 weeks (red) or 6 weeks (blue). (c,d) Filled circles represent individual cells (n = 15 cells per condition; Studentβs t-test; *, P > 0.05). (e) Representative traces (left) of spontaneous EPSCs and IPSCs recorded from GABAergic AD-iN cell when cocultured with Ngn2-induced glutamatergic neurons for 7 weeks. Arrowheads, network activity. Inset, expanded view of boxed area. Asterisks, EPSC-like events with fast kinetics (magenta) and IPSC-like events with slow kinetics (blue). Pie charts indicate cell fraction with EPSCs (magenta), IPSCs (blue) or both types of responses (mixed, green; n = 54 cells). (f) Representative image of grafted AD-iN cells identified by human nuclei antibodies (magenta) and expressed GABAergic neuron markers including GABA, CR, CB, SST, NPY and PV (green). Histogram shows percentage of human cells that express different markers.
LLM interpretation
This figure evaluates the functional maturation and identity of AD-iN cells through electrophysiological recordings and immunohistochemistry. Panels (a-d) use voltage traces and bar/scatter plots to show that AD-iN cells generate action potentials and exhibit increased spontaneous and evoked IPSC amplitude and frequency from 5 to 7 weeks post-induction (WPI). Panel (e) utilizes current traces and pie charts to demonstrate the presence of both EPSCs and IPSCs in cocultures, while panel (f) uses fluorescence microscopy and a histogram to show that grafted human cells express various GABAergic markers, with Calretinin (CR) being the most prevalent. Statistical significance is indicated by asterisks (*, P > 0.05) across several quantitative comparisons.
Induced GABAergic neurons for human neurological disease modeling. (a) Collybistin expression is reduced by shRNA knockdown (hairpin numbers 1β5) compared with control (Ctrl) in iN cells as measured by qRT-PCR (mean Β± s.e.m.). (b) Representative traces of postsynaptic currents induced by exogenous application of GABA (1 mM). (c,d) Cumulative (cum.) plots (i) and summary graphs (ii) show reduction in average peak amplitude (c) and total charge-transfer (d) of GABA puff-induced IPSCs in human Ngn2-iN cells subjected to collybistin knockdown. (e) Patchβclamp configuration for postsynaptic recordings performed on day 28β30 human neurons expressing collybistin shRNAs. Collybistin KD iN cells (EGFP positive) were cocultured with Ascl1, Dlx2, Myt1l-generated iN cells (EGFP negative, black arrowheads). Rec, recording electrode. Scale bars, 15 ΞΌm. (f) Sample traces of GABAAR- mediated spontaneous IPSCs recorded from control (top) or collybistin shRNA no. 4 (Sh# 4)-infected neurons (bottom). (g) Cumulative plots (left) and average graphs (right) representing mean Β± s.e.m. values of sIPSC amplitude (amp, i) and event frequency (freq, ii), recorded from control versus collybistin shRNA no. 4 β infected neurons in (e). Numbers inside bars indicate total number of independent batches (for batch-wise comparisons) or total number of cells recorded/number of batches. Two-tailed, unpaired Studentβs t-test; ***, P < 0.005; **, P < 0.01; *, P < 0.05; n.s., not significant. P > 0.05 was used for all comparisons except batch-wise comparisons, where paired t-tests were performed. For cumulative plots, circles represent average values recorded from individual cells.
LLM interpretation
This figure consists of multiple panels analyzing the effect of collybistin knockdown (KD) on GABAergic signaling in human iN cells. Panel (a) uses a bar chart to show reduced mRNA levels across five shRNA hairpins compared to control, while panels (b), (c), and (d) utilize electrophysiological traces, cumulative plots, and bar graphs to demonstrate a significant decrease in peak amplitude and total charge transfer of GABA-induced IPSCs. Panel (e) provides microscopy images of the patch-clamp configuration, and panels (f) and (g) show sample traces and quantitative data indicating a significant reduction in both the amplitude and frequency of spontaneous IPSCs in Sh#4-infected neurons. Statistical significance is indicated by asterisks (*P < 0.05, **P < 0.01, ***P < 0.005) across the summary graphs.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| 3D genetic architecture of schizophrenia risk across three neuronal subtypes. | Powell SK et al. | β | 2026 | β |
| Disrupted lipid homeostasis as a pathogenic mechanism in ABCA7-associated Alzheimer's disease risk. | Nam Y et al. | β | 2026 | β |
| Distinct synaptic mechanisms underlie NRXN1 variant and disorder background-dependent phenotypes in iPSC-derived neurons. | English J et al. | β | 2026 | β |
| Efficient generation of human dorsal spinal GABAergic progenitors for the treatment of spinal cord injury. | Feng X et al. | β | 2026 | β |
| Forward programming of human pluripotent stem cells to generate glutamatergic and GABAergic neurons in a tri-culture model with astrocytes. | Gu J et al. | β | 2026 | β |
| Generating and characterizing human telencephalic brain organoids from stem cell-derived single neural rosettes. | Ullah HMA et al. | β | 2026 | β |
| Generating LGE/CGE Organoids from Human Pluripotent Stem Cell-derived Brain Organoids Without External Signal Induction. | Zhu X et al. | β | 2026 | β |
| Human neuronal networks on micro-electrode arrays as a tool to assess genotype-phenotype correlation in CACNA1A-related disorders. | Hommersom MP et al. | β | 2026 | β |
| Presynaptic Trafficking of Glutamate Decarboxylase Isoforms Is Dispensable for Basal GABAergic Neurotransmission. | Benner O et al. | β | 2026 | β |
| Uncovering NMDA receptor-mediated high firing activity in excitatory human neurons. | Gameiro-Ros I et al. | β | 2026 | β |
| Unraveling the Morphological and Functional Maturation Mechanisms Underlying Human Neural Development Using iPSCs-Derived Neuronal Model. | Tian Y et al. | β | 2026 | β |
| Ascl1-mediated enhancement of GABAergic neuronal function in differentiated F11 cells under high glucose conditions. | Go EJ et al. | β | 2025 | β |
| CACNA1A loss-of-function affects neurogenesis in human iPSC-derived neural models. | Musante I et al. | β | 2025 | β |
| Cell fate acquisition and reprogramming by the proneural transcription factor ASCL1. | Lundie-Brown J et al. | β | 2025 | β |
| Cholecystokinin-expressing GABA neurons elicit long-term potentiation in the cortical inhibitory synapses and attenuate sound-shock associative memory. | Zhang G et al. | β | 2025 | β |
| Current Applications of Human Pluripotent Stem Cells in Neuroscience Research and Cell Transplantation Therapy for Neurological Disorders. | Verma I et al. | β | 2025 | β |
| Decoding microglial functions in Alzheimer's disease: insights from human models. | Rao C et al. | β | 2025 | β |
| Development and characterization of a scalable calcium imaging assay using human iPSC-derived neurons. | Haustein MD et al. | β | 2025 | β |
| Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. | Wang Y et al. | β | 2025 | β |
| Electrical stimulation of stem cell-derived human neural networks for evaluating anti-seizure medications. | Nicholls J et al. | β | 2025 | β |
| Functional Neurogenomics to Dissect Disease Mechanisms Across Models. | Zheng X et al. | β | 2025 | β |
| GABAergic synaptic components are largely preserved across human and mouse neuronal models. | Rebollo B et al. | β | 2025 | β |
| Generation of Glutamatergic Human Neurons from Induced Pluripotent Stem Cells. | Rizalar FS et al. | β | 2025 | β |
| Harnessing Intelligence from Brain Cells In Vitro. | Kagan BJ et al. | β | 2025 | β |
| Human Induced Pluripotent Stem Cells: Directed Differentiation Methods and Applications in Brain Diseases. | Wang Y et al. | β | 2025 | β |
| Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity and gradual electrochemical maturation. | Bershteyn M et al. | β | 2025 | β |
| Implications of gene Γ environment interactions in post-traumatic stress disorder risk and treatment. | Seah C et al. | β | 2025 | β |
| Improving Proteostasis of Trafficking-Deficient GABA<sub>A</sub> Receptor Variants by Activating IRE1. | Fu X et al. | β | 2025 | β |
| Insufficiency of 40S ribosomal proteins, RPS26 and RPS25, negatively affects biosynthesis of polyglycine-containing proteins in fragile-X associated conditions. | Tutak K et al. | β | 2025 | β |
| Modulation of pain sensitivity by Ascl1- and Lhx6-dependent GABAergic neuronal function in streptozotocin diabetic mice. | Hwang SM et al. | β | 2025 | β |
| mTORC1-selective inhibitors rescue cellular phenotypes in TSC iPSC-derived neurons. | Buttermore ED et al. | β | 2025 | β |
| Phenotypic complexities of rare heterozygous neurexin-1 deletions. | Fernando MB et al. | β | 2025 | β |
| PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia. | Kozlova A et al. | β | 2025 | β |
| Precision medicine approach for in vitro modeling and computational screening of anti-epileptic drugs in pediatric epilepsy patients with SCN2A (R1629L) mutation. | Kim J et al. | β | 2025 | β |
| Pulsed electromagnetic stimulation promotes neuronal maturation by up-regulating cholesterol biosynthesis. | Chen P et al. | β | 2025 | β |
| Single-cell chromatin accessibility landscape profiling reveals the diversity of epigenetic regulation in the rat nervous system. | Ma P et al. | β | 2025 | β |
| STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy, Experimental Models, and Translational Research. | Ruano-RodrΓguez S et al. | β | 2025 | β |
| Transcription Factor-Based Differentiation of Pluripotent Stem Cells: Overcoming the Traps of Random Neuronal Fate. | McDaid G et al. | β | 2025 | β |
| Transcriptomic characterization of maturing neurons from human neural stem cells across developmental time points. | Hosseini K et al. | β | 2025 | β |
| Aberrant neuronal connectivity and network activity of neurons derived from patients with idiopathic schizophrenia. | Heider J et al. | β | 2024 | β |
| ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations. | Afshar-Saber W et al. | β | 2024 | β |
| Analyses of the autism-associated neuroligin-3 R451C mutation in human neurons reveal a gain-of-function synaptic mechanism. | Wang L et al. | β | 2024 | β |
| Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders. | Vivi E et al. | β | 2024 | β |
| Cell-type-specific <i>cis</i>-regulatory divergence in gene expression and chromatin accessibility revealed by human-chimpanzee hybrid cells. | Wang B et al. | β | 2024 | β |
| Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder. | Tokatly Latzer I et al. | β | 2024 | β |
| Defined co-cultures of glutamatergic and GABAergic neurons with a mutation in DISC1 reveal aberrant phenotypes in GABAergic neurons. | Heider J et al. | β | 2024 | β |
| Generation of a stably transfected mouse embryonic stem cell line for inducible differentiation to excitatory neurons. | Gu J et al. | β | 2024 | β |
| Generation of human excitatory forebrain neurons by cooperative binding of proneural NGN2 and homeobox factor EMX1. | Ang CE et al. | β | 2024 | β |
| Harnessing the potential of human induced pluripotent stem cells, functional assays and machine learning for neurodevelopmental disorders. | Yang Z et al. | β | 2024 | β |
| iPSC-derived models of PACS1 syndrome reveal transcriptional and functional deficits in neuron activity. | Rylaarsdam L et al. | β | 2024 | β |
| Liprin-Ξ± proteins are master regulators of human presynapse assembly. | MarcΓ³ de la Cruz B et al. | β | 2024 | β |
| Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells. | Muhtaseb AW et al. | β | 2024 | β |
| Neuronal reprogramming of mouse and human fibroblasts using transcription factors involved in suprachiasmatic nucleus development. | Hirayama M et al. | β | 2024 | β |
| Parallelized engineering of mutational models using piggyBac transposon delivery of CRISPR libraries. | Nuttle X et al. | β | 2024 | β |
| Pharmacological chaperones restore proteostasis of epilepsy-associated GABA<sub>A</sub> receptor variants. | Wang YJ et al. | β | 2024 | β |
| Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models. | Sebastian R et al. | β | 2024 | β |
| Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington's disease. | Wu J et al. | β | 2024 | β |
| Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing. | Serafini MM et al. | β | 2024 | β |
| Scaled and efficient derivation of loss-of-function alleles in risk genes for neurodevelopmental and psychiatric disorders in human iPSCs. | Zhang H et al. | β | 2024 | β |
| Strategies for dissecting the complexity of neurodevelopmental disorders. | Sun J et al. | β | 2024 | β |
| Upregulated GIRK2 Counteracts Ethanol-Induced Changes in Excitability and Respiration in Human Neurons. | Prytkova I et al. | β | 2024 | β |
| Ascl1 and Ngn2 convert mouse embryonic stem cells to neurons via functionally distinct paths. | Vainorius G et al. | β | 2023 | β |
| ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity. | Abashkin DA et al. | β | 2023 | β |
| A transcription factor atlas of directed differentiation. | Joung J et al. | β | 2023 | β |
| E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function. | Wei Y et al. | β | 2023 | β |
| Excitatory Dysfunction Drives Network and Calcium Handling Deficits in 16p11.2 Duplication Schizophrenia Induced Pluripotent Stem Cell-Derived Neurons. | Parnell E et al. | β | 2023 | β |
| From cells to insights: the power of human pluripotent stem cell-derived cortical interneurons in psychiatric disorder modeling. | Ni P et al. | β | 2023 | β |
| GABAergic neurons differentiated from BDNF- and Dlx2-modified neural stem cells restore disrupted neural circuits in brainstem stroke. | Tang X et al. | β | 2023 | β |
| Generation and Co-culture of Cortical Glutamatergic and GABAergic-Induced Neuronal Cells. | English J et al. | β | 2023 | β |
| Generation of self-organized autonomic ganglion organoids from fibroblasts. | Liu S et al. | β | 2023 | β |
| Human-Derived Cortical Neurospheroids Coupled to Passive, High-Density and 3D MEAs: A Valid Platform for Functional Tests. | Muzzi L et al. | β | 2023 | β |
| Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease. | Young JE et al. | β | 2023 | β |
| <i>Bcl</i>-<i>xL</i> Promotes the Survival of Motor Neurons Derived from Neural Stem Cells. | Wu Y et al. | β | 2023 | β |
| Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk. | Powell SK et al. | β | 2023 | β |
| Integrating genetics and transcriptomics to study major depressive disorder: a conceptual framework, bioinformatic approaches, and recent findings. | Hicks EM et al. | β | 2023 | β |
| Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders. | Michalski C et al. | β | 2023 | β |
| Massively parallel functional dissection of schizophrenia-associated noncoding genetic variants. | Rummel CK et al. | β | 2023 | β |
| Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells. | Hong Y et al. | β | 2023 | β |
| Phenotypic complexities of rare heterozygous neurexin-1 deletions | Fernando MB et al. | β | 2023 | β |
| Protocol Optimization for Direct Reprogramming of Primary Human Fibroblast into Induced Striatal Neurons. | Kraskovskaya N et al. | β | 2023 | β |
| Shedding light on latent pathogenesis and pathophysiology of mental disorders: The potential of iPS cell technology. | Arioka Y et al. | β | 2023 | β |
| Stem Cell Models for Context-Specific Modeling in Psychiatric Disorders. | Seah C et al. | β | 2023 | β |
| Stem cell programmingΒ - prospects for perinatal medicine. | Berg LJ et al. | β | 2023 | β |
| The efficient induction of human retinal ganglion-like cells provides a platform for studying optic neuropathies. | Liou RH et al. | β | 2023 | β |
| Transcription Factor-Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells. | Ng YH et al. | β | 2023 | β |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Guerreiro S et al. | β | 2023 | β |
| What connects splicing of transfer RNA precursor molecules with pontocerebellar hypoplasia? | Sekulovski S et al. | β | 2023 | β |
| A Neural Crest-specific Overexpression Mouse Model Reveals the Transcriptional Regulatory Effects of Dlx2 During Maxillary Process Development. | Sun J et al. | β | 2022 | β |
| Application and prospects of high-throughput screening for <i>in vitro</i> neurogenesis. | Zhang SY et al. | β | 2022 | β |
| Ascl1 phospho-site mutations enhance neuronal conversion of adult cortical astrocytes <i>in vivo</i>. | Ghazale H et al. | β | 2022 | β |
| A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis. | Deneault E et al. | β | 2022 | β |
| Bringing to light the physiological and pathological firing patterns of human induced pluripotent stem cell-derived neurons using optical recordings. | Alich TC et al. | β | 2022 | β |
| Cadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks. | Mossink B et al. | β | 2022 | β |
| 'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies. | Simkin D et al. | β | 2022 | β |
| Diseased, differentiated and difficult: Strategies for improved engineering of <i>in vitro</i> neurological systems. | Elder N et al. | β | 2022 | β |
| Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation. | Woods LM et al. | β | 2022 | β |
| Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders. | Geertjens L et al. | β | 2022 | β |
| Generation of neuronal/glial mixed cultures from human induced pluripotent stem cells (hiPSCs). | Mangiameli E et al. | β | 2022 | β |
| Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids. | Barak M et al. | β | 2022 | β |
| <i>CASK</i> loss of function differentially regulates neuronal maturation and synaptic function in human induced cortical excitatory neurons. | McSweeney D et al. | β | 2022 | β |
| Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures. | Aversano S et al. | β | 2022 | β |
| Induction of synapse formation by de novo neurotransmitter synthesis. | Burlingham SR et al. | β | 2022 | β |
| Leveraging the Genetic Diversity of Human Stem Cells in Therapeutic Approaches. | Tegtmeyer M et al. | β | 2022 | β |
| Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation. | Hulme AJ et al. | β | 2022 | β |
| Mapping cis-regulatory elements in human neurons links psychiatric disease heritability and activity-regulated transcriptional programs. | Sanchez-Priego C et al. | β | 2022 | β |
| Microfluidics for Neuronal Cell and Circuit Engineering. | Habibey R et al. | β | 2022 | β |
| MIRA: joint regulatory modeling of multimodal expression and chromatin accessibility in single cells. | Lynch AW et al. | β | 2022 | β |
| Modeling Developmental Brain Diseases Using Human Pluripotent Stem Cells-Derived Brain Organoids - Progress and Perspective. | Bhattacharya A et al. | β | 2022 | β |
| Multielectrode Arrays for Functional Phenotyping of Neurons from Induced Pluripotent Stem Cell Models of Neurodevelopmental Disorders. | McCready FP et al. | β | 2022 | β |
| Neurodevelopmental copy-number variants: A roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact. | Commission on Novel Technologies for Neurodevelopmental Copy Number Variants | β | 2022 | β |
| Novel, Emerging Chip Models of the Blood-Brain Barrier and Future Directions. | Holloway PM | β | 2022 | β |
| Past, Present, and Future of Direct Cell Reprogramming. | Ahlenius H | β | 2022 | β |
| Patient-Derived InΒ Vitro Models of Microglial Function and Synaptic Engulfment in Schizophrenia. | Sheridan SD et al. | β | 2022 | β |
| Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells. | Pistollato F et al. | β | 2022 | β |
| Quantitative interactome proteomics identifies a proteostasis network for GABA<sub>A</sub> receptors. | Wang YJ et al. | β | 2022 | β |
| Research models of neurodevelopmental disorders: The right model in the right place. | Damianidou E et al. | β | 2022 | β |
| Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSC. | Fischer S et al. | β | 2022 | β |
| Advances in microfluidic in vitro systems for neurological disease modeling. | Holloway PM et al. | β | 2021 | β |
| Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia. | Michael Deans PJ et al. | β | 2021 | β |
| A Step-by-Step Refined Strategy for Highly Efficient Generation of Neural Progenitors and Motor Neurons from Human Pluripotent Stem Cells. | Ren J et al. | β | 2021 | β |
| Autologous Induced Pluripotent Stem Cell-Based Cell Therapies: Promise, Progress, and Challenges. | Madrid M et al. | β | 2021 | β |
| Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders. | Anderson NC et al. | β | 2021 | β |
| Common Genetic Variation in Humans Impacts InΒ Vitro Susceptibility to SARS-CoV-2 Infection. | Dobrindt K et al. | β | 2021 | β |
| Comparison of Acute Effects of Neurotoxic Compounds on Network Activity in Human and Rodent Neural Cultures. | Saavedra L et al. | β | 2021 | β |
| Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders. | Benchoua A et al. | β | 2021 | β |
| Defining the nature of human pluripotent stem cell-derived interneurons via single-cell analysis. | Allison T et al. | β | 2021 | β |
| Direct Differentiation of Functional Neurons from Human Pluripotent Stem Cells (hPSCs). | Hu R et al. | β | 2021 | β |
| Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application. | Vasan L et al. | β | 2021 | β |
| Direct reprogramming of oligodendrocyte precursor cells into GABAergic inhibitory neurons by a single homeodomain transcription factor Dlx2. | Boshans LL et al. | β | 2021 | β |
| Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors. | Chen SW et al. | β | 2021 | β |
| Efficient Derivation of Excitatory and Inhibitory Neurons from Human Pluripotent Stem Cells Stably Expressing Direct Reprogramming Factors. | Song S et al. | β | 2021 | β |
| Efficient generation of dopaminergic induced neuronal cells with midbrain characteristics. | Ng YH et al. | β | 2021 | β |
| Epigenetic regulation during human cortical development: Seq-ing answers from the brain to the organoid. | Lewis EMA et al. | β | 2021 | β |
| Functional Characterization of Human Pluripotent Stem Cell-Derived Models of the Brain with Microelectrode Arrays. | Pelkonen A et al. | β | 2021 | β |
| Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex. | Mich JK et al. | β | 2021 | β |
| Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2. | Zhu S et al. | β | 2021 | β |
| Generation of Induced Dopaminergic Neurons from Human Fetal Fibroblasts. | Legault EM et al. | β | 2021 | β |
| Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging. | Chao CC et al. | β | 2021 | β |
| Human Stem Cell-Derived GABAergic Interneurons Establish Efferent Synapses onto Host Neurons in Rat Epileptic Hippocampus and Inhibit Spontaneous Recurrent Seizures. | WaloschkovΓ‘ E et al. | β | 2021 | β |
| Human stem cell-derived GABAergic neurons functionally integrate into human neuronal networks. | Gonzalez-Ramos A et al. | β | 2021 | β |
| <i>In vivo</i> Direct Conversion of Astrocytes to Neurons Maybe a Potential Alternative Strategy for Neurodegenerative Diseases. | Wang Y et al. | β | 2021 | β |
| Impaired neuronal activity and differential gene expression in STXBP1 encephalopathy patient iPSC-derived GABAergic neurons. | Ichise E et al. | β | 2021 | β |
| Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia. | Bassil R et al. | β | 2021 | β |
| <i>NGN2</i> mmRNA-Based Transcriptional Programming in Microfluidic Guides hiPSCs Toward Neural Fate With Multiple Identities. | Tolomeo AM et al. | β | 2021 | β |
| Isolation and Neuronal Reprogramming of Mouse Embryonic Fibroblasts. | Adrian-Segarra JM et al. | β | 2021 | β |
| Joint profiling of histone modifications and transcriptome in single cells from mouse brain. | Zhu C et al. | β | 2021 | β |
| Mind the translational gap: using iPS cell models to bridge from genetic discoveries to perturbed pathways and therapeutic targets. | Pintacuda G et al. | β | 2021 | β |
| Modulating the Electrical and Mechanical Microenvironment to Guide Neuronal Stem Cell Differentiation. | Oh B et al. | β | 2021 | β |
| Neural In Vitro Models for Studying Substances Acting on the Central Nervous System. | Fritsche E et al. | β | 2021 | β |
| New Insights Into the Intricacies of Proneural Gene Regulation in the Embryonic and Adult Cerebral Cortex. | Oproescu AM et al. | β | 2021 | β |
| Programmatic introduction of parenchymal cell types into blood vessel organoids. | Dailamy A et al. | β | 2021 | β |
| Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia. | Dobrindt K et al. | β | 2021 | β |
| Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids. | Shcheglovitov A et al. | β | 2021 | β |
| Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly. | Jansch C et al. | β | 2021 | β |
| Stem Cells for Next Level Toxicity Testing in the 21st Century. | Fritsche E et al. | β | 2021 | β |
| The role of GABAergic signalling in neurodevelopmental disorders. | Tang X et al. | β | 2021 | β |
| Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion. | Wang X et al. | β | 2021 | β |
| Transcription Factor Programming of Human Pluripotent Stem Cells to Functionally Mature Astrocytes for Monocultures and Cocultures with Neurons. | Quist E et al. | β | 2021 | β |
| Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons. | Halikere A et al. | β | 2020 | β |
| Amyloid-Ξ²-independent regulators of tau pathology in Alzheimer disease. | van der Kant R et al. | β | 2020 | β |
| Application of induced pluripotent stem cells in epilepsy. | Hirose S et al. | β | 2020 | β |
| ASCL1- and DLX2-induced GABAergic neurons from hiPSC-derived NPCs. | Barretto N et al. | β | 2020 | β |
| BC-Box Motif in SOCS6 Induces Differentiation of Epidermal Stem Cells into GABAnergic Neurons. | Yoshizumi T et al. | β | 2020 | β |
| Cell Type-Specific In Vitro Gene Expression Profiling of Stem Cell-Derived Neural Models. | Gregory JA et al. | β | 2020 | β |
| Copy number variants (CNVs): a powerful tool for iPSC-based modelling of ASD. | Drakulic D et al. | β | 2020 | β |
| Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. | Sawada T et al. | β | 2020 | β |
| Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications. | Fantuzzo JA et al. | β | 2020 | β |
| Differential sensitivity of human neurons carrying ΞΌ opioid receptor (MOR) N40D variants in response to ethanol. | Scarnati MS et al. | β | 2020 | β |
| Direct Conversion of Human Stem Cell-Derived Glial Progenitor Cells into GABAergic Interneurons. | Giacomoni J et al. | β | 2020 | β |
| Direct Readout of Neural Stem Cell Transgenesis with an Integration-Coupled Gene Expression Switch. | Kumamoto T et al. | β | 2020 | β |
| Generation of cerebral cortical GABAergic interneurons from pluripotent stem cells. | Fitzgerald M et al. | β | 2020 | β |
| Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease. | Wu Z et al. | β | 2020 | β |
| Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy. | Seranova E et al. | β | 2020 | β |
| Human in vitro models for understanding mechanisms of autism spectrum disorder. | Gordon A et al. | β | 2020 | β |
| Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction. | Cheffer A et al. | β | 2020 | β |
| Identification of small molecules for accelerating the differentiation of GABA interneurons from human pluripotent stem cells. | Shen L et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| Interneuron Types as Attractors and Controllers. | Fishell G et al. | β | 2020 | β |
| Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells. | Powell SK et al. | β | 2020 | β |
| In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid. | Nam KH et al. | β | 2020 | β |
| Mapping regulators of cell fate determination: Approaches and challenges. | Kumar A et al. | β | 2020 | β |
| Massively parallel techniques for cataloguing the regulome of the human brain. | Townsley KG et al. | β | 2020 | β |
| Master Regulators and Cofactors of Human Neuronal Cell Fate Specification Identified by CRISPR Gene Activation Screens. | Black JB et al. | β | 2020 | β |
| Modeling genetic epilepsies in a dish. | Niu W et al. | β | 2020 | β |
| Modeling neuronal consequences of autism-associated gene regulatory variants with human induced pluripotent stem cells. | Ross PJ et al. | β | 2020 | β |
| Modeling the complex genetic architectures of brain disease. | Fernando MB et al. | β | 2020 | β |
| Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease. | Toniolo S et al. | β | 2020 | β |
| Neuronal Reprogramming for Tissue Repair and Neuroregeneration. | Liou RH et al. | β | 2020 | β |
| New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids. | Blair JD et al. | β | 2020 | β |
| Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery. | Marotta N et al. | β | 2020 | β |
| Profiling parvalbumin interneurons using iPSC: challenges and perspectives for Autism Spectrum Disorder (ASD). | Filice F et al. | β | 2020 | β |
| Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy. | Sterlini B et al. | β | 2020 | β |
| Protocol for the Standardized Generation of Forward Programmed Cryopreservable Excitatory and Inhibitory Forebrain Neurons. | Peitz M et al. | β | 2020 | β |
| Regeneration of Functional Neurons After Spinal Cord Injury via <i>in situ</i> NeuroD1-Mediated Astrocyte-to-Neuron Conversion. | Puls B et al. | β | 2020 | β |
| Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids. | Tian A et al. | β | 2020 | β |
| The Genetic Programs Specifying Kolmer-Agduhr Interneurons. | Yang L et al. | β | 2020 | β |
| Transcriptional Programming of Human Mechanosensory Neuron Subtypes from Pluripotent Stem Cells. | Nickolls AR et al. | β | 2020 | β |
| Transcription Factor-Based Fate Specification and Forward Programming for Neural Regeneration. | Flitsch LJ et al. | β | 2020 | β |
| Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells. | De Los Angeles A et al. | β | 2020 | β |
| Using human pluripotent stem cell models to study autism in the era of big data. | Nehme R et al. | β | 2020 | β |
| An Autaptic Culture System for Standardized Analyses of iPSC-Derived Human Neurons. | Rhee HJ et al. | β | 2019 | β |
| A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons. | Sridharan B et al. | β | 2019 | β |
| bHLH transcription factors in neural development, disease, and reprogramming. | Dennis DJ et al. | β | 2019 | β |
| Compartmentalized Devices as Tools for Investigation of Human Brain Network Dynamics. | Fantuzzo JA et al. | β | 2019 | β |
| CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons. | Tian R et al. | β | 2019 | β |
| Directed Differentiation of Pluripotent Stem Cells by Transcription Factors. | Oh Y et al. | β | 2019 | β |
| Directed glial differentiation and transdifferentiation for neural tissue regeneration. | Janowska J et al. | β | 2019 | β |
| Direct Neuronal Reprogramming Reveals Unknown Functions for Known Transcription Factors. | Colasante G et al. | β | 2019 | β |
| Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity. | Chanda S et al. | β | 2019 | β |
| From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies. | Duan J et al. | β | 2019 | β |
| Human Pluripotent Stem Cells as Tools for Predicting Developmental Neural Toxicity of Chemicals: Strategies, Applications, and Challenges. | Liang S et al. | β | 2019 | β |
| <i>In Vitro</i> Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of <i>PCDH1</i>5 and <i>RELN</i>. | Ishii T et al. | β | 2019 | β |
| Induced Neurons for the Study of Neurodegenerative and Neurodevelopmental Disorders. | Sauter EJ et al. | β | 2019 | β |
| Induced pluripotent stem cells for neural drug discovery. | Farkhondeh A et al. | β | 2019 | β |
| In Vitro Functional Characterization of Human Neurons and Astrocytes Using Calcium Imaging and Electrophysiology. | Hansen MG et al. | β | 2019 | β |
| Large-Scale Generation and Characterization of Homogeneous Populations of Migratory Cortical Interneurons from Human Pluripotent Stem Cells. | Ni P et al. | β | 2019 | β |
| Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. | van Hugte E et al. | β | 2019 | β |
| Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons. | Marro SG et al. | β | 2019 | β |
| Neuronal impact of patient-specific aberrant NRXN1Ξ± splicing. | Flaherty E et al. | β | 2019 | β |
| Organs to Cells and Cells to Organoids: The Evolution of <i>in vitro</i> Central Nervous System Modelling. | Pacitti D et al. | β | 2019 | β |
| Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons. | Lu C et al. | β | 2019 | β |
| Synergistic effects of common schizophrenia risk variants. | Schrode N et al. | β | 2019 | β |
| Transcriptome Analysis of Small Molecule-Mediated Astrocyte-to-Neuron Reprogramming. | Ma NX et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. | Mertens J et al. | β | 2018 | β |
| Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells. | Hoffmann A et al. | β | 2018 | β |
| Complete Disruption of Autism-Susceptibility Genes by Gene Editing Predominantly Reduces Functional Connectivity of Isogenic Human Neurons. | Deneault E et al. | β | 2018 | β |
| Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules. | Lee C et al. | β | 2018 | β |
| Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism. | Jung-Klawitter S et al. | β | 2018 | β |
| Induction of human somatostatin and parvalbumin neurons by expressing a single transcription factor LIM homeobox 6. | Yuan F et al. | β | 2018 | β |
| Mapping Cellular Reprogramming via Pooled Overexpression Screens with Paired Fitness and Single-Cell RNA-Sequencing Readout. | Parekh U et al. | β | 2018 | β |
| Modeling Pediatric Epilepsy Through iPSC-Based Technologies. | Simkin D et al. | β | 2018 | β |
| Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells. | Barnes J et al. | β | 2018 | β |
| Open chromatin dynamics reveals stage-specific transcriptional networks in hiPSC-based neurodevelopmental model. | Zhang S et al. | β | 2018 | β |
| Patient-Derived iPSCs and iNs-Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases. | Tang BL | β | 2018 | β |
| Precise nanoinjection delivery of plasmid DNA into a single fibroblast for direct conversion of astrocyte. | Park HS et al. | β | 2018 | β |
| Rapid and efficient induction of functional astrocytes from human pluripotent stem cells. | Canals I et al. | β | 2018 | β |
| Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological Disease. | Ghaffari LT et al. | β | 2018 | β |
| Selective vulnerability in neurodegenerative diseases. | Fu H et al. | β | 2018 | β |
| Transcription factor programming of human ES cells generates functional neurons expressing both upper and deep layer cortical markers. | Miskinyte G et al. | β | 2018 | β |
| Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. | Fink JJ et al. | β | 2018 | β |
| A prenatal interruption of DISC1 function in the brain exhibits a lasting impact on adult behaviors, brain metabolism, and interneuron development. | Deng D et al. | β | 2017 | β |
| Generation of pure GABAergic neurons by transcription factor programming. | Yang N et al. | β | 2017 | β |
| <i>Intellicount</i>: High-Throughput Quantification of Fluorescent Synaptic Protein Puncta by Machine Learning. | Fantuzzo JA et al. | β | 2017 | β |
| Neuronal replacement therapy: previous achievements and challenges ahead. | Grade S et al. | β | 2017 | β |
| On-demand optogenetic activation of human stem-cell-derived neurons. | Klapper SD et al. | β | 2017 | β |
| Radial glia in the ventral telencephalon. | Turrero GarcΓa M et al. | β | 2017 | β |